Inflammatory myopathies: Clinical sciences

Last updated: January 30, 2025

Inflammatory myopathies: Clinical sciences

TERM 2 - NB2

TERM 2 - NB2

Syringomyelia
Anatomy clinical correlates: Spinal cord pathways
Spinal cord disorders: Pathology review
Syringomyelia: Year of the Zebra
Anatomy of the brainstem
Anatomy of the diencephalon
Anatomy of the limbic system
Anatomy of the white matter tracts
Anatomy clinical correlates: Cerebellum and brainstem
Cranial nerve pathways
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Anatomy clinical correlates: Vertebral canal
Anatomy of the basal ganglia
Anatomy of the ventricular system
Spina bifida
Movement disorders: Pathology review
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Somatosensory pathways
Somatosensory receptors
Brown-Séquard syndrome: Year of the Zebra
Brown-Sequard Syndrome
Muscle spindles and golgi tendon organs
Central nervous system histology
Spinal infection and abscess: Clinical sciences
Spinal muscular atrophy
Skin histology
Neurocutaneous disorders: Pathology review
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Neuromuscular junction disorders: Pathology review
Approach to differentiating lesions (neuromuscular junction): Clinical sciences
Neuromuscular junction and motor unit
Myasthenia gravis: Clinical sciences
Neuromuscular blockers
Corynebacterium diphtheriae (Diphtheria)
Poliovirus
Lambert-Eaton myasthenic syndrome
Myasthenia gravis
Myasthenia gravis: Year of the Zebra 2024
Inflammatory myopathies: Clinical sciences
Basal ganglia: Direct and indirect pathway of movement
Parkinson disease
Anatomy clinical correlates: Cerebral hemispheres
Anatomy of the cerebellum
Cerebellum
Eye conditions: Retinal disorders: Pathology review
Coats disease: Year of the Zebra 2024
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Photoreception
Approach to acute vision loss: Clinical sciences
Optic pathways and visual fields
Vestibular transduction
Auditory transduction and pathways
Kluver-Bucy syndrome
Childhood and early-onset psychological disorders: Pathology review
Approach to neurodevelopmental disorders: Clinical sciences
Approach to diplopia: Clinical sciences

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 3 complete

Start
A 63-year-old man presents to the primary care clinic to establish care. He has not seen a doctor in several years. Over the past few years, he has gradually developed worsening weakness in the hands, forearms, and legs. He has trouble getting out of a chair and also trouble opening bottles and jars. He has no significant past medical history and does not take any medications. Vital signs are unremarkable. He appears frail. Muscle strength is 3/5 in the left forearm muscles, 4/5 in the right forearm, 3/5 in the right hip and quadricep, and 4/5 in the left hip and quadricep. Weakness of the distal finger flexor muscles is also noted. A random muscle biopsy shows inflammatory cells with vacuolated muscle fibers and amyloid deposits. Which of the following treatments is most appropriate?  

Transcript

Watch video only

Inflammatory myopathies are a group of autoimmune conditions associated with muscle inflammation and subsequent progressive muscle wasting and weakness. These conditions occur when immune cells like lymphocytes and macrophages infiltrate skeletal muscle fibers, causing widespread inflammation. Inflammatory myopathies include five conditions: dermatomyositis, antisynthetase syndrome, immune-mediated necrotizing myositis, inclusion body myositis, and polymyositis.

Now, if your patient presents with chief concerns suggesting inflammatory myopathy, your first step is to perform a focused history and physical. Patients usually report symptoms of proximal muscle weakness, commonly affecting the shoulder and pelvic girdle muscles. So, they might find it difficult to do activities like combing their hair, standing up from a sitting position, or climbing stairs. To remember this, think hair, chairs, and stairs! They might also report difficulty swallowing or a skin rash. Additionally, some individuals have a positive personal or family history of autoimmune or inflammatory diseases, like lupus, scleroderma, or Sjogren syndrome.

Finally, the physical examination can reveal symmetric proximal muscle weakness, with or without skin abnormalities like a rash.

At this point, you should suspect inflammatory myopathy, so be sure to order serum creatine kinase and electromyography, or EMG. Now, If your patient’s creatine kinase levels are normal and EMG reveals normal findings or evidence of neuropathy, consider an alternative diagnosis, like motor neuron disease, peripheral polyneuropathy, or myasthenia gravis. On the other hand, if labs reveal elevated creatine kinase, usually ten times the upper limit of normal or more, and the EMG shows a myopathic process, such as fibrillations and early recruitment of muscle fibers, diagnose inflammatory myopathy!

Here’s a clinical pearl to keep in mind! Non-inflammatory conditions, such as electrolyte imbalances, hypothyroidism, Cushing syndrome or adrenal insufficiency, can also result in myopathy, so you should always check serum electrolytes, magnesium, TSH and morning cortisol screen for these conditions

Alright, now once you confirm the presence of an inflammatory myopathy, your next step is to identify the underlying cause of muscle inflammation. First, order myositis-specific antibodies, such as anti-Mi-2 and anti-Jo-1 antibodies. However, keep in mind that these antibodies can be associated with more than one disease, so you will need to interpret the results along with history and physical exam findings. Also, don’t forget to obtain a muscle biopsy, which is the gold standard for diagnosis.

And here’s another clinical pearl! Once you confirm the diagnosis of inflammatory myositis, it's important to screen your patient for extramuscular manifestations and various associated malignancies. This might involve lung imaging and pulmonary function tests to detect interstitial lung disease; electrocardiography and echocardiography to detect cardiac disease; and cancer screening tests, like a mammogram and prostate examination, as well as an endoscopy or a colonoscopy.

Now, let’s have a look at various underlying causes of inflammatory myopathies, starting with dermatomyositis. As the name implies, it affects both the skin and the muscles. In this case, a physical exam typically reveals Gottron papules, which are raised red lesions over the knuckles; or Gottron sign, which is a red, flat, scaly rash over extensor surfaces of joints. Additionally, these patients often develop a Heliotrope rash, which refers to red-to-purple discoloration and edema of the eyelids.

Other findings include a V-sign, or v-shaped redness on the anterior neck and chest, and a shawl sign, which refers to a red discoloration on the back of the neck and shoulders. You might also notice nail bed telangiectasias and subcutaneous calcium deposits.

Now, one physical exam finding that distinguishes dermatomyositis from similar conditions like scleroderma and systemic lupus erythematosus is poikiloderma, which refers to areas of skin affected by skin atrophy, hyper- and hypopigmentation, that are typically seen in chronic disease; and telangiectasias. Also, in patients with dermatomyositis, the anti-Mi-2 antibodies are typically positive.

Finally, the muscle biopsy will reveal inflammation of the perimysium, which is a thin layer of fibrous tissue surrounding a muscle fascicle; as well as degeneration of muscle fibers. With these findings, diagnose dermatomyositis!

Sources

  1. "2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups [published correction appears in Arthritis Rheumatol 2018 Sep;70(9):1532]." Arthritis Rheumatol (2017;69(12):2271-2282. )
  2. "Treatment of inflammatory myopathies" Postgrad Med J. (2006;82(969):417-424.)
  3. "Muscle biopsy findings in inflammatory myopathies" Rheum Dis Clin North Am. (2002;28(4):779-vi. doi:10.1016/s0889-857x(02)00030-3)
  4. "Harrison’s Principles of Internal Medicine. 21st Edition. " New York, NY. McGraw Hill Education. (2022.)
  5. "Idiopathic Inflammatory Myopathies: Clinical Approach and Management. " Front Neurol. (2016;7:64. Published 2016 May 20)
  6. "Diagnosis and Management of Immune-Mediated Myopathies. " Mayo Clin Proc. (2017;92(5):826-837)
  7. "Clinical significance of myositis-specific autoantibodies. " Immunol Med. (2018;41(3):103-112. )
  8. "Skeletal Muscle Involvement in Antisynthetase Syndrome. " JAMA Neurol (2017;74(8):992-999.)
  9. "Immune-Mediated Necrotizing Myopathy. " Curr Rheumatol Rep. (2018;20(4):21. Published 2018 Mar 26. )
  10. "A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. " Clin Rev Allergy Immunol. (2017;52(1):1-19. )
  11. "Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis. " Auto Immun Highlights. (2014;5(3):77-85. Published 2014 Sep 10.)
  12. "The Diagnosis and Treatment of Antisynthetase Syndrome. " Clin Pulm Med. (2016;23(5):218-226.)